Biotech Food Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization
Mar
2
2023
FDA Withdraws Proposed Rule on General Principles for Food Standards Modernization Keller and Heckman LLP
Mar
2
2023
Consumer Fraud PFAS Cases Continue To Rise CMBG3 Law
Mar
1
2023
North Carolina Senate Passes Compassionate Care Act – at Exactly 4:20 p.m. Bradley Arant Boult Cummings LLP
Mar
1
2023
Desperate Times, Desperate Measuring Cups – FTC Brings Enforcement Action for False “Made in USA” Advertising ArentFox Schiff LLP
Mar
1
2023
Unpacking Averages: Exploring New Data on FDA Responses to FOIA Requests Epstein Becker & Green, P.C.
Feb
28
2023
FDA Asked to Allow “Healthy” Claims on Coffee Keller and Heckman LLP
Feb
28
2023
China Announces Draft Standard on Nutritional Fortification Substances: What Will its Impact Be on Alternative Protein Foods? Keller and Heckman LLP
Feb
28
2023
Will the U.S. Supreme Court Make Marijuana Legal? Bradley Arant Boult Cummings LLP
Feb
28
2023
This Week in 340B: February 21 – 27, 2023 McDermott Will & Emery
Feb
27
2023
Old North State Report – Feb. 27, 2023 Nelson Mullins
Feb
27
2023
FDA Publishes List of 2023 Priority Guidance Topics Keller and Heckman LLP
Feb
27
2023
DEA Announces Permanent Flexibilities for the Prescribing of Controlled Substances via Telemedicine Polsinelli PC
Feb
27
2023
DEA’s Proposed Rules on Telemedicine Controlled Substances Prescribing after the PHE Ends Foley & Lardner LLP
Feb
25
2023
No Surprises Act Update: Certified IDR Entities to Resume Payment Determinations for Services Furnished Before October 25, 2022 Sheppard, Mullin, Richter & Hampton LLP
Feb
25
2023
HHS-OIG Declines to Impose Sanctions on Drug Manufacturer for Financial Assistance to Pediatric Patients with Rare Disease Barnes & Thornburg LLP
Feb
24
2023
Cosmetics – Moving From Voluntary Compliance to Mandatory Regulation Beveridge & Diamond PC
Feb
24
2023
From the Year of the Tiger to the Year of the Rabbit Keller and Heckman LLP
Feb
24
2023
FDA Files Civil Money Penalty Complaints Against Four Small Vape Shops for Alleged Premarket Review Violations Keller and Heckman LLP
Feb
24
2023
Tenth Circuit Declares No Remedy for Hemp Farmer Whose Federally Legal Plants Were Seized ArentFox Schiff LLP
Feb
24
2023
FDA Releases Draft Guidance on Labeling of Plant-Based Milk Alternatives Keller and Heckman LLP
Feb
23
2023
Coverage for Rotten Eggs: Livestock Coverage in the Event of a Crisis Hunton Andrews Kurth
Feb
23
2023
Modified REMS, Clarification on Mailing Drugs, and Movement in Texas Case Mark Significant Weeks in the Reproductive Health Legal Sphere ArentFox Schiff LLP
Feb
23
2023
THC-Oh No! The DEA Classifies Delta-8 and Delta-9 THCO as Controlled Substances Bradley Arant Boult Cummings LLP
Feb
23
2023
Walking the Highwire of Affiliate Marketing and Advertising Claims [PODCAST] Greenberg Traurig, LLP
Feb
22
2023
CMS Releases Guidance on Implementation of Rebate Programs for Certain Medicare Part B and Part D Drugs Sheppard, Mullin, Richter & Hampton LLP
Feb
21
2023
Lawsuit Alleges PFAS in Pomegranate Juice Keller and Heckman LLP
Feb
21
2023
The 2023 Farm Bill and the Future of Hemp Bradley Arant Boult Cummings LLP
Feb
20
2023
Old North State Report – Feb. 20, 2023 Nelson Mullins
Feb
18
2023
EPA Announces Both EPA and FDA Seek Public Input on Modernizing Their Approach to Oversight of Certain Products Bergeson & Campbell, P.C.
Feb
17
2023
Delta-What??!!- Delta-8 and Delta-9 Create High Anxiety for Policymakers Norris McLaughlin P.A.
Feb
17
2023
Bankruptcy Court Dismisses Cannabis Company Employee’s Chapter 13 Case Squire Patton Boggs (US) LLP
Feb
17
2023
FDA Sued for Denying Petition Related to Antibiotic Use Keller and Heckman LLP
Feb
16
2023
FDA Issues Guidance on Protein Quality Studies for Infant Formula Keller and Heckman LLP
Feb
15
2023
You Can Go Your Own Way: Washington’s Cannabis License Residency Requirement Upheld, Breaking the Chain of Contrary Decisions Bradley Arant Boult Cummings LLP
Feb
14
2023
FDA Issues Warning Letter to RightEye, LLC For Misbranding and Adulteration Sheppard, Mullin, Richter & Hampton LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins